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ABSTRACT 
Transforming growth factor beta 1 (TGF-β1) is a key 
regulator that modulates male reproductive function. 
Testicular TGF-β1 modulates the steroidogenesis of 
Leydig cells, the organization of peritubular myoid 
cells, testis development and spermatogenesis. Several 
studies have indicated that TGF-β1 is involved in the 
tight balance between proliferative and apoptotic re- 
sponses in the Leydig cells. In the present review, we 
summarize the direct effects of this cytokine in Ley- 
dig cells under normal and pathological conditions. 
We analyze the effect of TGF-β1 in Leydig cells de- 
pending on the type of receptors involved in the sig- 
naling pathway of TGF-β1. Our group has been ana- 
lyzing the canonical and non canonical intracellular 
signaling pathways of TGF-β1 that are involved in the 
expression of proliferative and apoptotic markers in 
Leydig cells. On the basis of our studies and from 
those of other authors we conclude that the balance 
between the expression of TGF-β1 receptors and co 
receptors is of relevance in Leydig cell physiology and 
pathophisiology. 
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1. INTRODUCTION 
The normal function of the testis has long been recog- 
nized to be dependent on gonadotropins hormones. Nu- 
merous reports over the past years have clearly indicated 
that locally produced factors may play an important role 
in the regulation of Leydig cell functions. In this context, 
many factors produced locally in the testes that act in a 
paracrine and/or autocrine manner are able to have plei- 
otropic actions on Leydig cell homeostasis. Particularly, 
the transforming growth factor beta (TGF-β) family mem- 
bers play important roles in Leydig cell differentiation, 
proliferation and secretory functions. This review will 
focus on two aspects: first, the localization of TGF-β1 
system in the testis of different species and second, the 
action and signaling pathways of the TGF-β1 involved in 
a mechanism that controls Leydig cell proliferation. 
1.1. The TGF-β Family 
The TGF-β family controls diverse cellular processes in- 
cluding cell proliferation, differentiation, migration and 
apoptosis [1]. TGF-β family comprises more than 30 pro- 
teins that share between 30% to 80% sequence homology 
[1]. The best characterized members of this family in- 
clude five isoforms of TGF-β (TGF-β1-5), inhibins, ac- 
tivins, bone morphogenetic proteins (BMPs), anti-Mul- 
lerian Hormone (AMH) and growth and differentiation 
factors (GDFs) [2,3]. TGF-β members have an important 
role during embryogenesis, organogenesis and mainte- 
nance of tissue homeostasis during adult life [4]. In addi- 
tion, deregulation of the TGF-β signaling has been im- 
plicated in the progression of diseases such as cancer and 
autoimmune fibrosis [5].  
In reproductive tissues, TGF-β members regulate the 
development of the gonads and accessory sex glands, 
spermatogenesis, immunoregulation of pregnancy, embr- 
yo implantation and placental development [6]. 
1.2. Localization of TGF-β1 in the Testis 
Five isoforms of TGF-β encoded by different genes have 
been described [7-9]. TGF-β1, TGF-β2 and TGF-β3 are 
expressed in the mammalian testis whereas TGF-β4 and 
5 are expressed in birds and toads [6]. Particularly, tes- 
ticular TGF-β1 modulates a variety of cellular processes, *Corresponding author. 
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comprising the secretory function of Leydig cells, the or- 
ganization of peritubular myoid cells, testis development 
and spermatogenesis [9-11]. TGF-β has been detected 
both in somatic cells (Leydig cells, peritubular myoid cells 
and Sertoli cells) and germ cells from different species 
including pigs, rats, mice, hamsters and humans [12-15]. 
It has been also demonstrated that different factors such 
as age, photoperiod or pathological conditions modulate 
the expression of TGF-β1 in the testis [16-18]. 
1.3. The TGF-β Receptors in the Testis 
Five type II and seven type I receptors that bind mem- 
bers of the TGF-β family have been identified in mam- 
mals [19-21]. These receptors are transmembrane pro- 
teins with an intracellular serine/threonine kinase domain. 
TGF-β type II receptors include the receptors for activin 
(ActR-IIA, ActR-IIB), BMPs (BMPRII), AMH (AMHR- 
II) and TGF-β (TGF-βRII) [3]. TGF-β type I receptors 
(TGF-βRI) comprise the activin like receptor kinase 
(ALK) 1 - 7, which can be classified in three groups ac- 
cording to their sequence. The first group includes ALK- 
5, ALK-4, ALK-7 and GDFs receptor. The second group 
consists of the two BMP type I receptors, ALK-3 and 
ALK-6. Finally, in the third group, are included the ALK- 
1 and ALK-2 receptors [22]. The receptors involved in 
the TGF-β1 action are the TGF-βRII and TGF-βRI, par- 
ticularly, ALK-1 and ALK-5 [9,23-25]. The presence of 
TGF-βRII and ALK-5 receptors has been extensively de- 
monstrated in Leydig cells, Sertoli cells and germ cells 
from mice [14], rats [26], boars [18], pigs [27], hamsters 
[15] and humans [13,28]. ALK-1 receptor was recently 
observed in Leydig cells from mice [14], hamsters [15] 
and humans [28]. 
Other receptors capable of binding TGF-β members 
are TGF-β receptor type III (TGF-βRIII) or betaglycan 
[29] and the co-receptor endoglin [30,31]. The presence 
of TGF-βRIII has been characterized in the testicular 
cells [32] but endoglin receptor was characterized prima- 
rily in endothelial cells [33]. Recently, the expression of 
the protein and mRNA of endoglin has been reported in 
Leydig cells from human and mouse testis [14,28]. The 
pattern of expression of the TGF-β receptors in a given 
cell leads to different responses exerted by TGF-β1 (see 
below).  
1.4. Canonical and Non-Canonical TGF-β1  
Signal Transduction Pathway 
The TGF-β receptors have the ability to associate as ho- 
momeric and heteromeric complexes. In this context, 
TGF-βRII forms homodimers regardless of TGF-β bind- 
ing and is constitutively autophosphorylated [34,35]. TGF- 
βRI also forms homodimers independently of ligand and 
binding. Both ALK-1 and ALK-5 are not able to effi- 
ciently bind to the ligand, except when they are associ- 
ated with the TGF-βRII. Therefore, the binding of TGF- 
β1 to TGF-βRII induces the recruitment and phosphory- 
lation of ALK-1 and/or ALK-5 receptors and triggers the 
intracellular signal transduction through the Smad pro- 
teins (namely canonical mechanism) [4]. Eight different 
Smad proteins are encoded by the human and mouse ge- 
nome [4]. Only five Smad proteins (Smad1, Smad2, 
Smad3, Smad5 and Smad8) act as a substrate for the 
TGF-β receptors and are called R-Smads [5]. In this con- 
text, ALK-1 receptor signals via the phosphorylation of 
Smads 1/5 and ALK-5 receptor signals via the phospho- 
rylation of Smads 2/3 [8]. This process induces the trans- 
duction of the extracellular signal of TGF-β1 activating 
downstream gene transcription [19,20,36,37].   
The presence of Smad proteins in the testis has not 
been thoroughly studied. At present, it has been describ- 
ed in rats, i.e. the expression of the Smads 1, 2 and 3 in 
Leydig cells, Sertoli cells and germ cells [38,39]. In 
mouse postnatal testis, Smad1 has been detected in sper- 
matocytes and round spermatids [40]. In the prepubertal 
mouse testis, the expression of Smad5 has been reported 
in spermatogonia cells [41]. In the human testis, Smad 1, 
2, 3 and 5 have been localized in Leydig cells and semi- 
niferous tubules [28,42].  
Besides these intracellular mechanisms involving Smad 
proteins, TGF-β1 exerts its action via non-smads proteins 
(namely non-canonical mechanism), particularly, JNK (Jun 
N-terminal kinase), p38 MAPK (mitogen-activated pro- 
tein kinase p38) and ERK (extracellular-signal-regulat- 
ed kinase) [43-45]. The first evidence of this mechanism 
comes from observations in which TGF-β1 can activate 
the ERK signalling pathway promoting the activation of 
p21 (cell cycle inhibitory factor) in intestine and lung 
epithelial cells from rats [46]. At present, the best charac- 
terized TGF-β1 signalling pathway that does not involve 
Smad proteins is the JNK and p38 MAPK pathway [47]. 
A direct demonstration of this mechanism is based on re- 
sults performed in murine mammary epithelial cells with 
a mutation in the TGF-βRI receptor at the binding and 
phosporilating Smads sites. It was observed that this mu- 
tated receptor is capable to induce an intracellular re- 
sponse in the presence of TGF-β1 activating JNK and 
p38 MAPK pathways and leading to cell apoptosis [48, 
49]. 
2. INVOLVEMENT OF TGF-β1 IN 
LEYDIG CELL PROLIFERATION 
TGF-β1 exerts a crucial role in cell proliferation, differ- 
entiation and apoptosis. Although the mechanism of TGF- 
β1 signalling has been studied in different experimental 
conditions, the action of this cytokine in testis homeosta- 
sis has been poorly analyzed. It is well known that TGF- 
β1 inhibits the growth of most cell types, including epi-  
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thelial cells, endothelial cells, fibroblasts and hematopoi- 
etic cells [50]. On the other hand, it has been observed 
that TGF-β1 is able to stimulate cell proliferation in skin 
fibroblasts and endothelial cells [50]. In this context, it 
has been shown the activation of the TGF-βRII and sub- 
sequently of ALK-5 and Smad2/3 by TGF-β1 leads to a 
regulation of the gene promoters for the cyclin dependent 
kinases (CDK) to suppress their transcription [50]. Smad 
proteins are responsible for the transcriptional activation 
of the two major cyclin inhibitors: p15 and p21. Both are 
responsible for inhibiting the activity of CDK proteins 
that allow the progression from G1 to S phase of the cell 
cycle, leading to cell cycle arrest in G1 phase [4,50]. In 
human prostate cells, gastric cells and astrocytes it was 
observed that the incubation with TGF-β1 promotes apo- 
ptosis by enhancing the levels of p15 and p21 [51-54]. In 
ovarian tumor cells, the treatment with TGF-β leads to an 
increase in p15 levels and phosphorylation of Smad2 
[55]. In the testis, it has been described that the incuba- 
tion of hamster Leydig cells with TGF-β1 stimulated p15 
expression in a mechanism that involves the participation 
of ALK-5 receptor and activation of p38 MAPK [15]. In 
line with this, Wu et al. [45] observed that TGF-β1 acti- 
vates the p38 pathway leading to cell apoptosis in murine 
podocytes. There is no direct evidence that TGF-β1 via 
p38 MAPK induces apoptosis of Leydig cells, although 
exists different reports that propose the participation of 
this MAPK in the apoptosis of germ cells in rodents [56]. 
However, studies reported by Gonzalez et al. [15], indi- 
cated that the Leydig cells from hamsters with maximal 
testicular photoperiodic regression are quiescent and ex- 
press a marked increased of p15 which leads to an arrest 
of cellular cycle and not necessarily leads the cells to 
apoptosis.   
It is important to point out, that TGF-β1 exerts bifunc- 
tional effects on cell proliferation, a mechanism highly 
described in endothelial cells [57]. In this experimental 
model, Lebrin et al. [57] showed that TGF-β1 is able to 
induce or inhibit cell proliferation. In these “in vitro” 
studies, low doses of TGF-β1 stimulated endothelial cell 
proliferation, whereas high doses of TGF-β1 inhibited 
this response [33,57]. The results obtained in endothelial 
cells, showed that the bifunctional effect of TGF-β1 is 
the result of the balance between the expression of ALK- 
5 and ALK-1 receptors. Whereas ALK-5 is responsible 
for the inhibition of proliferation, ALK-1 has the oppo- 
site effect [57]. In line with this, the co-receptor endoglin 
plays a fundamental role. Extracellular and cytoplasmic 
domains of endoglin interact with ALK-1 receptor en- 
hancing its signal transduction via the Smad1/5 protein 
pathway and interfering with ALK-5-Smad2/3 signaling 
[31,57-59]. Experiments performed on endothelial cells 
lacking the co-receptor endoglin, showed that these cells 
were not able to proliferate because the signalling path- 
way of TGF-β1 that involves the activation of ALK-1 
receptor is reduced, whereas the ALK-5 receptor signal- 
ling pathway is stimulated [57]. Then, expression of the 
coreceptor endoglin is essential to generate a prolifera- 
tive cell response in the presence of TGF-β1. It has been 
recently described that low doses of TGF-β1 enhanced 
the expression of the early growth response factor-1 (egr- 
1) and Krüppel-like factor 14 (KLF14) in TM3 Leydig 
cells [60]. Both KLF14 and egr-1 are transcription fac- 
tors responsible for the regulation of the transcription of 
various genes. Scanning of the promoter region of en- 
doglin gene, one site for egr-1 and eight sites for KLF 
family members were detected [60]. Egr-1 is involved in 
cell growth, differentiation, and survival [61]. In this con- 
text, Hou et al. [61] have reported that TGF-β1 is able to 
induce a rapid and transient accumulation of egr-1 pro- 
tein and mRNA in human skin fibroblasts. On the other 
hand, it has been described that KLF14 is a protein up- 
regulated by TGF-β1 that represses TGF-βRII [62]. The 
effect of TGF-β1 on the induction of KLF14 and egr-1, 
promotes the expression of endoglin, which leads TGF- 
β1 to promote the signaling pathway of proliferation 
[60].   
In addition, other factors involving hormonal regula- 
tion can modulate the expression of endoglin. It has been 
described in mouse Leydig cells, that progesterone is 
able to induce the expression of the co receptor endoglin 
[63] and, that the effect of low concentrations of TGF-β1 
plus progesterone showed an increased in the proliferat- 
ing cell nuclear antigen (PCNA) expression and a de- 
crease in Bax (pro-apoptotic gene) expression [63]. In 
the same work, the authors reported a clear increase in 
Smad1/5 phosporylation after mouse Leydig cell incuba- 
tion with TGF-β1 and progesterone [63]. In the testis, the 
control of the Leydig cell proliferation exerted by TGF- 
β1 was confirmed using the non-tumoral mouse Leydig 
cell line TM3. In this model, the gene expression of p15 
was induced by low doses TGF-β1 [60]. The presence of 
progesterone in the incubation media, induced the ex- 
pression of endoglin and the proliferative marker PCNA 
and abolished the stimulatory effect of TGF-β1 on p15 
expression [60]. In this regard, it has been described that 
Smad proteins activate the transcription of p15, which 
inhibits CDK-6 and CDK-4 proteins, influencing the cel- 
lular cycle and leading to a quiescent state of the cells 
[53,54,64]. Therefore, the effects of TGF-β1 on cell pro- 
liferation and cell cycle arrest would depend on the bal- 
ance between ALK-1 and ALK-5 receptors and the ex- 
pression of endoglin in the cell.   
3. EXPRESSION OF THE TGF-β1 
SYSTEM IN THE HYPERPLASIA OF 
LEYDIG CELLS 
It has been described in a variety of tissues that TGF-β1 
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and its receptors are altered in pathological conditions 
such as cancer and hyperplasia [65]. The identification of 
factors involved in the progression of testicular patholo- 
gies such as Leydig cell hyperplasia (LCH) is crucial to 
understand this pathology.  
Studies performed in experimental animals have shown 
that Leydig cell hyperplasia (LCH) may be induced by 
hormones and alterations in the production of paracrine 
growth factors [66]. It is known that LH, androgens or 
estrogens stimulate the proliferation of Leydig cells [67, 
68]. Concerning this issue, it has been reported that Ley- 
dig cells of transgenic mice over-expressing TGF-β1 are 
prominent [69]. In a model of transgenic mice over ex- 
pressing hCG which show hyperplasia and hyperthtropy 
of Leydig cells, the expression of TGF-β1, ALK-1 and co 
receptor endoglin was increased respect to control ani- 
mals [14]. Moreover, morphometric studies revealed that 
the “in vivo” intratesticular injection of normal mouse 
testis with TGFG-β1 plus progesterone caused an in- 
crease in the volume of Leydig cells [63]. 
In patients with certain testicular pathologies, the his- 
tological patterns found are hypospermatogenesis, Ger- 
minal Arrest and Sertoli cells only Syndrome (SCO) with 
and without focus of spermatogenesis [70]. It has been 
reported that in some of these patients, Leydig cells show 
hyperplasia, characterized by the presence of small nod- 
ules, often bilateral, thus being a benign pathology for 
the patient [71]. Dobashi et al. [72] have described that 
the serum levels of TGF-β1 were higher in patients with 
SCO than in normal controls. Gonzalez et al. [28] have 
shown that in patients that present LCH associated with 
SCO or hypospermatogenesis, the expression of TGF-β1 
protein and mRNA was higher than in patients with SCO 
or hipospermatogenesis alone.  
Although the expression of TGF-β1, TGF-βRII and 
ALK-5 receptors has long been described [13,72], scarce 
information is known about the localization of ALK-1 
and co receptor endoglin in human testis both in normal 
and pathological conditions. Recently, it has been de- 
scribe the presence of ALK-1 receptor and co receptor 
endoglin in Leydig cells from normal and pathological 
testicular biopsies [28]. Moreover, an increased in the ex- 
pression of these two receptors has been detected in pa- 
tients with LCH [28]. 
4. CONCLUSION 
In conclusion, the effect that TGF-β1 exerts on the pro- 
liferation of Leydig cells does not primarily depend on 
factors such as the concentration of this cytokine in the 
cell environment, but more importantly, depends on the 
type of receptors and co receptors present in the Leydig 
cells. The description of the action of TGF-β1 in the tes-
tis contributes to enlarging our knowledge on Leydig cell 
regulation and might be a clue to study signaling path-
ways to key outcomes in male reproductive health. 
5. ACKNOWLEDGEMENTS 
This study was supported by Grants from Consejo Nacional de Inves- 
tigaciones Científicas y Técnicas (CONI-CET), Agencia Nacional de 
Promoción Científica y Técnica (ANPCyT) and Facultad de Medicina- 
Universidad de Buenos Aires, Argentina. 
 
REFERENCES 
[1] Massagué, J. and Wotton, D. (2000) Transcriptional con- 
trol by TGF-/Smad signaling system. The EMBO Journal, 
19, 1745-1754.  
http://dx.doi.org/10.1093/emboj/19.8.1745 
[2] Lin, S.J., Lerch, T.F., Cook, R.W., Jardetzky, T.S. and 
Woodruff, T.K. (2006) The structural basis of TGF-beta, 
bone morphogenic protein, and activin ligand binding. Re- 
production, 132, 179-190.  
http://dx.doi.org/10.1530/rep.1.01072 
[3] Massagué, J. and Gomis, R.R. (2006) The logic of TGFbe- 
ta signaling. FEBS Letters, 580, 2811-2820.  
http://dx.doi.org/10.1016/j.febslet.2006.04.033 
[4] Massagué, J. (1998) TGF-beta signal transduction. An- 
nual Review of Biochemistry, 67, 753-791.  
http://dx.doi.org/10.1146/annurev.biochem.67.1.753 
[5] Blobe, G.C., Schiemann, W.P. and Lodish, H.F. (2000) 
Role of transforming growth factor beta in human disease. 
New England Journal of Medicine, 342, 1350-1358.  
http://dx.doi.org/10.1056/NEJM200005043421807 
[6] Ingman, W.V. and Robertson, S.A. (2002) Defining the 
actions of transforming growth factor beta in reproduc- 
tion. Bioessays, 24, 904-914.  
http://dx.doi.org/10.1056/NEJM200005043421807 
[7] ten Dijke, P., Hansen, P., Iwata, K.K., Pieler, C. and Foul- 
kes, J.G. (1988) Identification of another member of the 
transforming growth factor type gene family. Proceeding 
of the National Academy of Science, 85, 4715-4719.  
http://dx.doi.org/10.1073/pnas.85.13.4715 
[8] Feng, X.H. and Derynck, R. (2005) Specificity and versa- 
tility in TGF-beta signaling through Smads. Annual Re- 
view of Cell and Developmental Biology, 21, 659-693.  
http://dx.doi.org/10.1146/annurev.cellbio.21.022404.1420
18 
[9] Itman, C., Mendis, S., Barakat, B. and Loveland, K.L. 
(2006) All in the family: TGF-family action in testis de- 
velopment. Reproduction, 132, 233-246.  
http://dx.doi.org/10.1530/rep.1.01075 
[10] Gautier, C., Levacher, C., Saez, J.M. and Habert, R. (1997) 
Transforming growth factor beta1 inhibits steroidogenesis 
in dispersed fetal testicular cells in culture. Molecular and 
Cellular Endocrinology, 131, 21-30.  
http://dx.doi.org/10.1016/0303-7207(94)90146-5 
[11] Gnessi, L., Fabbri, A. and Sprera, G. (1997) Gonadal pep- 
tides as mediators of development and functional control 
of the testis: An integrated system with hormones and lo- 
cal environment. Endocrine Review, 18, 541-609.  
http://dx.doi.org/10.1210/er.18.4.541 
Copyright © 2013 SciRes.                                                                        OPEN ACCESS 
G. C. Rocio et al. / Advances in Bioscience and Biotechnology 4 (2013) 1-7 5
[12] Avallet, O., Vigier, M., Leduque, P., Dubois, P.M. and 
Saez, J.M. (1994) Expression and regulation of trans- 
forming growth factor-beta 1 messenger ribonucleic acid 
and protein in cultured porcine Leydig and Sertoli cells. 
Endocrinology, 134, 2079-2087.  
http://dx.doi.org/10.1210/en.134.5.2079  
[13] Zhang, Y.Q., He, X.Z., Zhang, J.S., Wang, R.A., Zhou, J. 
and Xu, R.J. (2004) Stage-specific localization of trans- 
forming growth factor beta1 and beta3 and their receptors 
during spermatogenesis in men. Asian Journal of Andro- 
lology, 6, 105-109.  
[14] Gonzalez, C.R., Gonzalez, B., Rulli, S.B., Huhtaniemi, I., 
Calandra, R.S. and Gonzalez-Calvar, S.I. (2010) TGF-β1 
system in Leydig cells. Part I: Effect of hCG and proges- 
terone. Journal of Reproduction and Development, 56, 
389-395. http://dx.doi.org/10.1262/jrd.09-166N 
[15] Gonzalez, C.R., Calandra, R.S. and Gonzalez-Calvar, S.I. 
(2012) Influence of the photoperiod on TGF-β1and p15 
expression in hamster Leydig cells. Reproductive Biology, 
12, 201-218.  
http://dx.doi.org/10.1016/S1642-431X(12)60086-2 
[16] Teerds, K.J. and Dorrington, J.H. (1993) Localization of 
transforming growth factor 1 and 2 during testicular de- 
velopment in the rat. Biology of Reproduction, 48, 40-45.  
http://dx.doi.org/10.1095/biolreprod48.1.40 
[17] Gautier, C., Levacher, C., Avallet, O., Vigier, M., Rouil- 
ler-Fabre, V., Lecerf, L., et al. (1994) Immunohistoche- 
mical localization of transforming growth factor-beta 1 in 
the fetal and neonatal rat testis. Molecular and Cellular 
Endocrinolology, 99, 55-61.  
http://dx.doi.org/10.1016/0303-7207(94)90146-5 
[18] Caussanel, V., Tabone, E., Hendrick, J.C., Dacheux, F. 
and Benahmed, M. (1997) Cellular distribution of trans- 
forming growth factor betas 1, 2, and 3 and their types I 
and II receptors during postnatal development and sper- 
matogenesis in the boar testis. Biology of Reproduction, 
56, 357-367.  
http://dx.doi.org/10.1095/biolreprod56.2.357 
[19] Shi, Y. and Massagué, J. (2003) Mechanisms of TGF-sig- 
naling from cell membrane to the nucleus. Cell, 113, 
685-700. 
http://dx.doi.org/10.1016/S0092-8674(03)00432-X 
[20] ten Dijke, P. and Hill, C.S. (2004) New insights into 
TGF-Smad signaling. Trends in Biochemical Sciences, 29, 
265-273. http://dx.doi.org/10.1016/j.tibs.2004.03.008 
[21] Suszko, M.I. and Woodruff, T.K. (2006) Cell-specificity 
of transforming growth factor-beta response is dictated by 
receptor bioavailability. Journal of Molecular Endocrino- 
logy, 36, 591-600. http://dx.doi.org/10.1677/jme.1.01936 
[22] de Caestecker, M. (2004) The transforming growth fac- 
tor-beta superfamily of receptors. Cytokine Growth Fac- 
tor Review, 15, 1-11.  
http://dx.doi.org/10.1016/j.cytogfr.2003.10.004 
[23] Frazen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, 
P., Heldin, C.H., et al. (1993) Cloning of a TCF type I re- 
ceptor that forms a heteromeric complex with the TGF 
type II receptor. Cell, 75, 681-692.  
http://dx.doi.org/10.1016/0092-8674(93)90489-D 
[24] Lux, A., Attisano, L. and Marchuk, D.A. (1999) Assign- 
ment of transforming growth factor 1 and 3 and a third 
new ligand to the type I receptor ALK-1. Journal of Bio- 
logical Chemistry, 274, 9984-9992.  
http://dx.doi.org/10.1074/jbc.274.15.9984 
[25] Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Dona- 
hoe, P.K., et al. (2000) Activin receptor like kinase 1 
(ALK-1) modulates TGF 1 signalling in regulation of an- 
giogenesis. Proceeding of the National Academic of Sci- 
ence, 97, 2626-2631.  
http://dx.doi.org/10.1073/pnas.97.6.2626 
[26] Olaso, R., Pairault, C. and Habert, R. (1998) Expression 
of type I and II receptors for transforming growth factor 
beta in the adult rat testis. Histochemistry and Cell Biol- 
ogy, 110, 613-618.  
http://dx.doi.org/10.1007/s004180050324 
[27] Goddard, I., Bouras, M., Keramidas, M., Hendrick, J.C., 
Feige, J.J. and Benahmed, M. (2000) Transforming growth 
factor-beta receptor types I and II in cultured porcine 
Leydig cells: Expression and hormonal regulation. Endo- 
crinology, 141, 2068-2074.  
http://dx.doi.org/10.1210/en.141.6.2068 
[28] Gonzalez, C.R., Matzkin, M.E., Frungieri, M.B., Terradas, 
C., Ponzio, R., Puigdomenech, E., et al. (2010) Expres- 
sion of the TGF-beta1 system in human testicular patho- 
logies. Reproductive Biology and Endocrinology, 8, 148- 
159. http://dx.doi.org/10.1186/1477-7827-8-148 
[29] Wang, X.F., Lin, H.Y., Ng-Eaton, E., Downward, J., Lo- 
dish, H.F. and Weinberg, R.A. (1991) Expression cloning 
and characterization of the TGF-beta type III receptor. 
Cell, 67, 797-805.  
http://dx.doi.org/10.1016/0092-8674(91)90074-9 
[30] Gougos, A. and Letarte, M. (1990) Primary structure of 
endoglin, an RGD-containing glycoprotein of human en- 
dothelial cells. Journal of Biological Chemistry, 265, 
8361-8364.  
[31] Koleva, R.I., Conley, B.A., Romero, D., Riley, K.S., Mar- 
to, J.A., Lux, A., et al. (2006) Endoglin structure and 
function: Determinants of endoglin phosphorylation by 
transforming growth factor-beta receptors. Journal of Bi- 
ological Chemistry, 281, 25110-25123.  
http://dx.doi.org/10.1074/jbc.M601288200 
[32] MacConel, L.A., Leal, A.L. and Vale, W.W. (2002) The 
distribution of betaglycan protein and mRNA in rat brain, 
pituitary, and gonads: implications for a role for betagly- 
can in inhibin-mediated reproductive functions. Endocri- 
nology, 143, 1066-1075.  
http://dx.doi.org/10.1210/en.143.3.1066 
[33] Lebrin, F., Goumans, M.J., Jonker, L., Carvalho, R.L., Val- 
dimarsdottir, G., Thorikay, M., et al. (2004) TGF-beta/ 
ALK1 Endoglin promotes endothelial cell proliferation 
and signal transduction. The EMBO Journal, 23, 4018- 
4028. http://dx.doi.org/10.1038/sj.emboj.7600386 
[34] Mathews, L.S. and Vale, W.W. (1993) Characterization 
of type II activin receptors. Binding, processing and pho- 
sphorylation. Journal of Biological Chemistry, 268, 19013- 
19018.  
[35] Chen, R.H. and Derynck, R. (1994) Homomeric interac- 
tions between the type II TGF-receptors. Journal of Bio- 
logical Chemistry, 269, 22868-22874.  
Copyright © 2013 SciRes.                                                                        OPEN ACCESS 
G. C. Rocio et al. / Advances in Bioscience and Biotechnology 4 (2013) 1-7 6 
[36] Massagué, J. (2000) How cells read TGF-beta signals. 
Nature Reviews. Molecular Cell Biology, 1, 169-178.  
[37] Massagué, J., Seoane, J. and Wotton, D. (2005) Smad 
transcription factors. Genes & Development, 19, 2783- 
2810. http://dx.doi.org/10.1101/gad.1350705 
[38] Xu, J., Beyer, A.R., Walker, W.H. and McGee, E.A. 
(2003) Developmental and stage-specific expression of 
Smad2 and Smad3 in rat testis. Journal of Andrology, 24, 
192-200.  
[39] Maire, M., Florin, A., Kaszas, K., Regnier, D., Contard, 
P., Tabone, E., et al. (2005) Alteration of transforming 
growth factor-beta signaling system expression in adult 
rat germ cells with a chronic apoptotic cell death process 
after fetal androgen disruption. Endocrinology, 146, 
5135-5143. http://dx.doi.org/10.1210/en.2005-0592 
[40] Zhao, G.Q. and Hogan, B.L.M. (1997) Evidence that 
Mothers-against-dpp-related 1 (Madr1) plays a role in 
the initiation and maintenance of spermatogenesis in the 
mouse. Mechanisms of Development, 61, 63-73.  
http://dx.doi.org/10.1016/S0925-4773(96)00622-3 
[41] Pellegrini, M., Grimaldi, P., Rossi, P., Germia, R. and 
Dolci, S. (2003) Development expression of BMP4/ 
ALK3/SMAD5 signaling pathway in the mouse testis: A 
potential role of BMP4 in spermatogonia differentiation. 
Journal of Cell Science, 116, 3363-3372.  
http://dx.doi.org/10.1242/jcs.00650 
[42] Sun, T., Xin, Z., Jin, Z., Wu, Y. and Gong, Y. (2008) Ef- 
fect of TGF-/Smad signalling on Sertoli Cell and possi- 
ble mechanism related to complete Sertoli Cell-only Syn- 
drome. Molecular and Cellular Biochemistry, 319, 1-7.  
http://dx.doi.org/10.1007/s11010-008-9869-3 
[43] Derynck, R. and Feng, X.H. (1997) TGF-receptor signal- 
ing. Biochimica et Biophysica Acta, 1333, F105-F150.  
[44] Javelaud, D. and Mauviel, A. (2005) Crosstalk mecha- 
nisms between the mitogen-activated protein kinase path- 
ways and Smad signaling downstream of TGF-: Impli- 
cations for carcinogenesis. Oncogene, 24, 5742-5750.  
http://dx.doi.org/10.1038/sj.onc.1208928 
[45] Wu, D.T., Bitzer, M., Ju, W., Mundel, P. and Bottinger, 
E.P. (2005) TGF- concentration specifies differential 
signaling profiles of growth arrest/differentiation and 
apoptosis in podocytes. Journal of the American Society 
of Nephrology, 16, 3211-3221.  
http://dx.doi.org/10.1681/ASN.2004121055 
[46] Yan, Z., Winawer, S. and Friedman, E. (1994) Two dif- 
ferent signal transduction pathways can be activated by 
transforming growth factor beta 1 in epithelial cells. 
Journal of Biological Chemistry, 269, 13231-13237.  
[47] Zhang, Y.E. (2009) Non-Smad pathways in TGF-beta 
signaling. Cellular Research, 19, 128-139.  
http://dx.doi.org/10.1038/cr.2008.328 
[48] Yu, L., Hébert, M.C. and Zhang, Y.E. (2002) TGF-beta 
receptor-activated p38 MAP kinase mediates Smad-in- 
dependent TGF-beta responses. The EMBO Journal, 21, 
3749-3759. http://dx.doi.org/10.1093/emboj/cdf366 
[49] Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., 
Itoh, F. and Heldin, C.H. (2003) Elucidation of Smad re- 
quirement in transforming growth factor-beta type I re- 
ceptor-induced responses. Journal of Biological Chemis- 
try, 278, 3751-3761.  
http://dx.doi.org/10.1074/jbc.M208258200 
[50] Huang, S.S. and Huang, J.S. (2005) TGF-beta control of 
cell proliferation. Journal of Cellular Biochemistry, 96, 
447-462. http://dx.doi.org/10.1002/jcb.20558 
[51] Rich, J.N., Zhang, M., Datto, M.B., Bigner, D.D. and 
Wang, X.F. (1999) Transforming growth factor-beta-me- 
diated p15INK4B induction and growth inhibition in astro- 
cytes is SMAD3-dependent and a pathway prominently 
altered in human glioma cell lines. Journal of Biological 
Chemistry, 274, 35053-35058.  
http://dx.doi.org/10.1074/jbc.274.49.35053 
[52] Robson, C.N., Gnanapragasam, V., Byrne, R.L. and 
Collins, A.T. (1999) Transforming growth factor-beta 1 
up-regulates p15, p21 and p27 and blocks cell cycling in 
G1 in human prostate epithelium. Journal of Endocrino- 
logy, 160, 257-266.  
http://dx.doi.org/10.1677/joe.0.1600257 
[53] Li, X., Zhang, Y.Y., Wang, Q. and Fu, S.B. (2005) Asso- 
ciation between endogenous gene expression and growth 
regulation induced by TGF-beta1 in human gastric cancer 
cells. World Journal of Gastroenterology, 11, 61-68.  
[54] Li, Z., Chen, Y., Cao, D., Wang, Y., Chen, G., Zhang, S., 
et al. (2002) Glucocorticoid up-regulates transforming 
growth factor-beta (TGF-beta) type II receptor and en- 
hances TGF-beta signaling in human prostate cancer 
PC-3 cells. Endocrinology, 147, 5259-5267.  
http://dx.doi.org/10.1210/en.2006-0540 
[55] Dunfield, L.D., Dwyer, E.J. and Nachtigal, M.W. (2002) 
TGF beta-induced Smad signaling remains intact in pri- 
mary human ovarian cancer cells. Endocrinology, 143, 
1174-1181. http://dx.doi.org/10.1210/en.143.4.1174 
[56] Pastor, L.M., Zuasti, A., Ferrer, C., Bernal-Mañas, C.M., 
Morales, E., Beltrán-Frutos, E., et al. (2011) Proliferation 
and apoptosis in aged and photoregressed mammalian se- 
miniferous epithelium, with particular attention to rodents 
and humans. Reproduction in Domestic Animals, 46, 155- 
164. http://dx.doi.org/10.1111/j.1439-0531.2009.01573.x 
[57] Lebrin, F., Deckers, M., Bertolino, P. and ten Dijke, P. 
(2005) TGF- receptor function in the endothelium. Car- 
diovascular Research, 65, 599-608.  
http://dx.doi.org/10.1016/j.cardiores.2004.10.036 
[58] Gougos, A. and Letarte, M. (1990) Primary structure of 
endoglin, an RGD-containing glycoprotein of human en- 
dothelial cells. Journal of Biological Chemistry, 265, 
8361-8364.  
[59] Blanco, F.J., Santibanez, J.F., Guerrero-Esteo, M., Langa, 
C., Vary, C.P. and Bernabeu, C. (2005) Interaction and 
functional interplay between endoglin and ALK-1, two 
components of the endothelial transforming growth fac- 
tor-beta receptor complex. Journal of Cell Physiology, 
204, 574-584. http://dx.doi.org/10.1002/jcp.20311 
[60] Gonzalez, C.R., Vallcaneras, S.S., Calandra, R.S. and 
Gonzalez-Calvar, S.I. (2013) Involvement of KLF14 and 
egr-1 in the TGF-beta1 action on Leydig cell proliferation. 
Cytokine, 61, 670-675.  
http://dx.doi.org/10.1016/j.cyto.2012.12.009 
[61] Hou, X., Arvisais, E.W., Jiang, C., Chen, D., Roy, S.K., 
Copyright © 2013 SciRes.                                                                        OPEN ACCESS 
G. C. Rocio et al. / Advances in Bioscience and Biotechnology 4 (2013) 1-7 
Copyright © 2013 SciRes.                                                                        
7
OPEN ACCESS 
Pate, J.L., et al. (2008) Prostaglandin F2α stimulates the 
expression and secretion of transforming growth factor 
B1 via induction of the early growth response 1 gene 
(EGR1) in the bovine corpus luteum. Molecular Endo- 
crinology, 22, 403-414.  
http://dx.doi.org/10.1210/me.2007-0272 
[62] Truty, M.J., Lomberk, G., Fernandez-Zapico, M.E. and 
Urrutia, R. (2009) Silencing of the transforming growth 
factor-beta (TGFbeta) receptor II by Krüppel-like factor 
14 underscores the importance of a negative feedback 
mechanism in TGFbeta signaling. Journal Biological 
Chemistry, 284, 6291-6300.  
http://dx.doi.org/10.1074/jbc.M807791200 
[63] Gonzalez, C.R., Gonzalez, B., Rulli, S.B., Dos Santos, 
M.L., Mattos Jardim Costa, G., França, L.R., et al. (2010) 
TGF-beta1 system in Leydig Cells. Part II: TGF-beta1 
and progesterone, through Smad1/5, are involved in the 
hyperplasia/hypertrophy of Leydig cells. Journal of Re- 
production and Development, 56, 400-404.  
[64] Feng, X.-H., Lin, X. and Derynck, R. (2000) Smad2, 
Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B 
transcription in response to TGF-beta. The EMBO Jour- 
nal, 19, 5178-5193.  
http://dx.doi.org/10.1093/emboj/19.19.5178 
[65] Kim, I.Y., Kim, M.M. and Kim, S.-J. (2005) Transform- 
ing growth factor-β: Biology and clinical relevance. Jour- 
nal of Biochemistry and Molecular Biology, 38, 1-8.  
http://dx.doi.org/10.5483/BMBRep.2005.38.1.001 
[66] Clegg, E.D., Cook, J.C., Chapin, R.E., Foster, P.M. and 
Daston, G.P. (1997) Leydig cell hyperplasia and adenoma 
formation: Mechanisms and relevance to humans. Repro- 
ductive Toxicology, 11, 107-121.  
http://dx.doi.org/10.1016/S0890-6238(96)00203-1 
[67] Ge, R.S. and Hardy, M.P. (1997) Decreased cyclin A2 
and increased cyclin G1 levels coincide with loss of pro- 
liferative capacity in rat Leydig cells during pubertal de- 
velopment. Endocrinology, 138, 3719-3726.  
http://dx.doi.org/10.1210/en.138.9.3719 
[68] Gould, M.L., Hurst, P.R. and Nicholson, H.D. (2007) The 
effects of oestrogen receptors alpha and beta on testicular 
cell number and steroidogenesis in mice. Reproduction, 
134, 271-279. http://dx.doi.org/10.1530/REP-07-0025 
[69] Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, 
P., Wakefield, L., et al. (1995) Hepatic expression of ma- 
ture transforming growth factor beta 1 in transgenic mice 
results in multiple tissue lesions. Proceedings of the Na- 
tional Academic of Science USA, 92, 2572-2576.  
[70] Anniballo, R., Ubaldi, F., Cobellis, L., Sorrentino, M., 
Rienzi, L., Greco, E., et al. (2000) Criteria predicting the 
absence of spermatozoa in the Sertoli Cell-only Syn- 
drome can be used to improve success rates of sperm re- 
trieval. Human Reproduction, 15, 2269-2277.  
http://dx.doi.org/10.1093/humrep/15.11.2269 
[71] Carucci, L.R., Tirkes, A.T., Pretorius, E.S., Genega, E.M. 
and Weinstein, S.P. (2003) Testicular Leydig’s cell hy- 
perplasia: MR imaging and sonographic findings. AJR 
American Journal of Roentgenology, 180, 501-503.  
http://dx.doi.org/10.2214/ajr.180.2.1800501 
[72] Dobashi, M., Fujisawa, M., Yamasaki, T., Okada, I. and 
Kamido. S. (2002) Distribution of intracellular and ex- 
tracellular expression of transforming growth factorb1 
(TGF-β1) in human testis and their association with sper- 
matogenesis. Asian Journal of Andrology, 4, 105-109. 
 
 
 
 
 
 
